ghk-cu pharmacokinetics subcutaneous SubQ vs IM Injection — Which Route Works Better? GHK-Cu Peptide: Benefits, Dosing &

There is no robust evidence for its safety or effectiveness in humans

Natural levels of this essential building block deplete over time, but topical application can help skin appear smoother and more youthful

If combining with an active treatment, timing recommendations should come from your provider

This review focuses on the main substrates, inhibitors and reactions played by cytosolic GSTs, with an eye on their relevance for human disease

Raza A, Galili N, Smith S, Godwin J, Lancet J, Melchert M et al

The standard injection dosage of 1 to 2 mg per day, subcutaneously, five days per week, covers most therapeutic goals